First Trust Nasdaq Pharmaceuticals ETF FTXH
41.71 USD -0.37 (-0.87%)
Regular-session close
42.34 +0.63 +1.52%
After hours · Nov 20, 6:59 PM ET
41.68 Day range 42.59
31.54 52-week range 45.10
- YTD
- +26.62%
- 1 year
- +32.66%
First Trust Nasdaq Pharmaceuticals ETF
- Issuer
- First Trust
- Asset class
- Sector Equity
- Expense ratio
- 0.60%
- Assets under management
- $1.21B
- NAV
- 44.35
- Holdings
- 50
- Inception
- 2016-09-20
- Top 10 weight
- 56.06%
Top holdings
- LLY Eli Lilly and Company 8.28%
- ABBV AbbVie Inc. 7.66%
- JNJ Johnson & Johnson 7.06%
- PFE Pfizer Inc. 6.89%
- MRK Merck & Co., Inc. 6.70%
- VTRS Viatris Inc. 4.22%
- BIIB Biogen Inc. 3.91%
- GILD Gilead Sciences, Inc. 3.90%
- REGN Regeneron Pharmaceuticals, Inc. 3.83%
- AMGN Amgen Inc. 3.62%
- ZTS Zoetis Inc. 3.57%
- UTHR United Therapeutics Corporation 3.42%
- VRTX Vertex Pharmaceuticals Incorporated 3.36%
- INCY Incyte Corporation 3.23%
- BMY Bristol-Myers Squibb Company 3.14%
- EXEL Exelixis, Inc. 2.63%
- JAZZ Jazz Pharmaceuticals Plc 2.61%
- ILMN Illumina, Inc. 1.66%
- MEDP Medpace Holdings, Inc. 1.53%
- HALO Halozyme Therapeutics, Inc. 1.38%
- NBIX Neurocrine Biosciences, Inc. 1.34%
- ELAN Elanco Animal Health Incorporated 1.28%
- CRL Charles River Laboratories International, Inc. 1.12%
- BMRN BioMarin Pharmaceutical Inc. 1.12%
- MRNA Moderna, Inc. 0.83%
Sector weights
- Healthcare 100.00%
Country weights
- United States 99.49%
- United Kingdom 0.51%
Updated 2026-11-11
Held by funds
2 US ETFs and mutual funds hold FTXH · largest positions
